{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:19Z","timestamp":1792097359592,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173901,82450103,82373962"],"award-info":[{"award-number":["82173901,82450103,82373962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["JC0002"],"award-info":[{"award-number":["JC0002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ8180"],"award-info":[{"award-number":["2024JJ8180"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JC0002"],"award-info":[{"award-number":["2021JC0002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733973"],"award-info":[{"award-number":["2023M733973"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2023ZD0506900"],"award-info":[{"award-number":["2023ZD0506900"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canlet.2025.218168","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T23:37:06Z","timestamp":1763854626000},"page":"218168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1\/PD-L1 inhibitors"],"prefix":"10.1016","volume":"639","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-871X","authenticated-orcid":false,"given":"Lei","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Long","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-9232","authenticated-orcid":false,"given":"Howard L.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5724-1516","authenticated-orcid":false,"given":"Zhao-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.218168_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.22.01503","article-title":"Five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer in CheckMate 227","volume":"41","author":"Brahmer","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218168_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1470-2045(21)00650-1","article-title":"Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial","volume":"23","author":"Zhou","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.218168_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.218168_bib4","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.218168_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/clinchem\/hvaa081","article-title":"Investigational biomarkers for checkpoint inhibitor immune-related adverse event prediction and diagnosis","volume":"66","author":"von Itzstein","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2025.218168_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaoncol.2019.0393","article-title":"Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2025.218168_bib9","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fimmu.2020.02023","article-title":"Predictive biomarkers of immune checkpoint inhibitors-related toxicities","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218168_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2017.12.008","article-title":"Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease","volume":"91","author":"Danlos","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-18-2795","article-title":"Circulating cytokines predict immune-related toxicity in melanoma patients receiving Anti-PD-1-Based immunotherapy","volume":"25","author":"Lim","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218168_bib12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/cas.14363","article-title":"Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors","volume":"111","author":"Kurimoto","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.218168_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009399","article-title":"Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1\/PD-L1 inhibitors","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-024-01285-9","article-title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events","volume":"16","author":"Hu","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2025.218168_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","article-title":"Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1","volume":"28","author":"McCulloch","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.218168_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt.1483","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity: successes, shortcomings, and future avenues of research","volume":"106","author":"Drogemoller","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2025.218168_bib17","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/s41591-022-02094-6","article-title":"Germline variants associated with toxicity to immune checkpoint blockade","volume":"28","author":"Groha","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.218168_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006570","article-title":"Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors","volume":"11","author":"Caulfield","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1096806","article-title":"Association between germ-line HLA and immune-related adverse events","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218168_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41591-022-02095-5","article-title":"IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma","volume":"28","author":"Taylor","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.218168_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218168_bib22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.apsb.2021.10.007","article-title":"Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer","volume":"12","author":"Mao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2025.218168_bib23","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1158\/1078-0432.CCR-21-0921","article-title":"Immunotherapy-mediated thyroid dysfunction: genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer","volume":"27","author":"Luo","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218168_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41418-022-01041-9","article-title":"UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation","volume":"30","author":"Tao","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.218168_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ejhg.2017.133","article-title":"NDUFAF4 variants are associated with leigh syndrome and cause a specific mitochondrial complex I assembly defect","volume":"25","author":"Baertling","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2025.218168_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1433961","article-title":"Role of mitochondria in inflammatory lung diseases","volume":"15","author":"Narala","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.218168_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200710-1602OC","article-title":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury","volume":"178","author":"Zmijewski","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2025.218168_bib28","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1074\/jbc.M112.400929","article-title":"Silencing alpha1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectin-mediated cell adhesion","volume":"288","author":"Buffone","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.218168_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893365","article-title":"N-Glycosylation and inflammation; the not-so-sweet relation","volume":"13","author":"Radovani","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218168_bib30","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.2741\/3051","article-title":"Protein tyrosine phosphatases in the JAK\/STAT pathway","volume":"13","author":"Xu","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2025.218168_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.21147\/j.issn.1000-9604.2023.03.09","article-title":"PTPRD\/PTPRT mutation correlates to treatment outcomes of immunotherapy and immune landscape in pan-cancers","volume":"35","author":"Wang","year":"2023","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218168_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991091","article-title":"PTPRD\/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types","volume":"13","author":"Shang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218168_bib33","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3390\/ijms19092708","article-title":"Protein tyrosine phosphatases as potential regulators of STAT3 signaling","volume":"19","author":"Kim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218168_bib34","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41388-021-01768-8","article-title":"Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via STAT3 dephosphorylation in nasopharyngeal carcinoma","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218168_bib35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00432-021-03550-5","article-title":"Inflammatory markers in autoimmunity induced by checkpoint inhibitors","volume":"147","author":"Husain","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218168_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000842","article-title":"Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition","volume":"8","author":"Laino","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep4.1717","article-title":"Hepcidin signaling in health and disease: ironing out the details","volume":"5","author":"Kowdley","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.canlet.2025.218168_bib38","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6 induces hepcidin expression through STAT3","volume":"108","author":"Wrighting","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.218168_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","article-title":"Hepcidin and iron in health and disease","volume":"74","author":"Nemeth","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canlet.2025.218168_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2020-143139","article-title":"Genetic variants that influence fetal hemoglobin expression from hydroxyurea treatment","volume":"136","author":"Marahatta","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.218168_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.redox.2015.09.025","article-title":"Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in nitric oxide treated hepatoblastoma cells","volume":"5","author":"Pena","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2025.218168_bib42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2008-05-155978","article-title":"Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway","volume":"113","author":"Flevaris","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.218168_bib43","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1002\/ptr.8317","article-title":"Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1\/Cdc42\/JNK pathway through a potential target of 5-HTR2A","volume":"38","author":"Liu","year":"2024","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2025.218168_bib44","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood.V89.8.2664","article-title":"Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3","volume":"89","author":"Nagata","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.218168_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03658.x","article-title":"The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation","volume":"8","author":"Severin","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.canlet.2025.218168_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2006.11.008","article-title":"The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway","volume":"26","author":"Blonska","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2025.218168_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.20011508","article-title":"c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation","volume":"195","author":"Conze","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.218168_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1499014","article-title":"The function of T cells in immune thrombocytopenia","volume":"16","author":"Bu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218168_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104808","article-title":"T cell-mediated mechanisms of immune-related adverse events induced by immune checkpoint inhibitors","volume":"213","author":"Li","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2025.218168_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejca.2023.01.034","article-title":"Immunogenetic variations predict immune-related adverse events for PD-1\/PD-L1 inhibitors","volume":"184","author":"Xin","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2025.218168_bib51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s43018-023-00572-5","article-title":"Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer","volume":"4","author":"Sung","year":"2023","journal-title":"Nat. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:40:31Z","timestamp":1792096831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525007402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":51,"alternative-id":["S0304383525007402"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218168","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1\/PD-L1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218168"}}